Преса о нас. Cтатьи:

1

АНТИВИРУСНЫЕ И ИММУНОМОДУЛИРУЮЩИЕ СВОЙСТВА ПРЕПАРАТА ИЗ ПРОРОСШЕГО ЗЕРНА ПШЕНИЦЫ «ЖИЗНЬ»

А.П. Левицкий, И.Г. Маник, С.А. Демьяненко

 
1 ГУ "Институт стоматологии АМН Украины"
2 ЧП "И.Г. Маник" торговая марка «ЖИЗНЬ»  - производитель и поставщик ростков пшеницы и сока из ростков пшеницы. 

2 УНИКАЛЬНЫЕ ЦЕЛЕБНЫЕ СВОЙСТВА СОКА ПРОРОСТКОВ ПШЕНИЦЫ И ЯЧМЕНЯ

Александр Ильичь РЫБАЛКА
зав. отделом качества зерна
(Селекционно-генетический институт, г. Одесса)
Доктор Биологических Наук. Академик Нью-Йоркской Академии Наук.

3 РАЦИОНАЛЬНАЯ ПРОФИЛАКТИКА ВИРУСНЫХ ИНФЕКЦИЙ

1. Левицкий Анатолий Павлович. Доктор Биологических Наук, Профессор, Член-Корреспондент Украинской Академии Наук
Заместитель директора по научной работе Института стоматологии АМН Украины, профессор кафедры пищевых технологий, Одесской национальной академии пищевых технологий. Председатель Совета НПА.Научно Производственная ассоциация "Одесская биотехнология"

2. ЧП "И.Г. Маник" торговая марка «ЖИЗНЬ»
производитель и поставщик ростков пшеницы и сока из ростков пшеницы.

г. Одесса

 Ссылки на статьи ученых  мирового значения  из различных научно исследовательских институтов и лабораторий мира о воздействии белка TRIM 5 ALPHA на ВИЧ инфекцию:

http://www.ncbi.nlm.nih.gov/pubmed/14985764
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
PMID: 14985764 [PubMed - indexed for MEDLINE]
  

Калифорния, США

http://www.ncbi.nlm.nih.gov/pubmed/17028189
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entry.
Chatterji U, Bobardt MD, Gaskill P, Sheeter D, Fox H, Gallay PA.
Departments of Immunology, Molecular and Integrative Neurosciences, and Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
PMID: 17028189 [PubMed - indexed for MEDLINE]

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/17156811
Unique features of TRIM5alpha among closely related human TRIM family members.
Li X, Gold B, O'hUigin C, Diaz-Griffero F, Song B, Si Z, Li Y, Yuan W, Stremlau M, Mische C, Javanbakht H, Scally M, Winkler C, Dean M, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 17156811 [PubMed - indexed for MEDLINE]

Нью-Йорк ,США

http://www.ncbi.nlm.nih.gov/pubmed/16828831
Antiretroviral potential of human tripartite motif-5 and related proteins.
Zhang F, Hatziioannou T, Perez-Caballero D, Derse D, Bieniasz PD.
Aaron Diamond AIDS Research Center and the Laboratory of Retrovirology, the Rockefeller University, 455 First Avenue, New York, NY 10016, USA.
PMID: 16828831 [PubMed - indexed for MEDLINE]

Лондон,  Великобритания
 
http://www.ncbi.nlm.nih.gov/pubmed/15649369
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
Yap MW, Nisole S, Stoye JP.
Division of Virology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
PMID: 15649369 [PubMed - indexed for MEDLINE]

Париж, Франция
 
http://www.ncbi.nlm.nih.gov/pubmed/18613956
Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
Carthagena L, Parise MC, Ringeard M, Chelbi-Alix MK, Hazan U, Nisole S.
Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Département des Maladies Infectieuses, 22 rue Méchain, 75014, Paris, France. laetitia.carthagena@inserm.fr
PMID: 18613956 [PubMed - indexed for MEDLINE]   PMCID: PMC2483995

Теннеси, США

http://www.ncbi.nlm.nih.gov/pubmed/18497858
Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ, Aiken C.
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
PMID: 18497858 [PubMed - indexed for MEDLINE]   PMCID: PMC2374908

Амстердам, Голландия

http://www.ncbi.nlm.nih.gov/pubmed/18248091
The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
van Manen D, Rits MA, Beugeling C, van Dort K, Schuitemaker H, Kootstra NA.
Department of Clinical Viro Immunology, Sanquin Research, Landsteiner Laboratory, University of Amsterdam, Amsterdam, The Netherlands.
PMID: 18248091 [PubMed - indexed for MEDLINE]   PMCID: PMC2222955

Хьюстон,  США

http://www.ncbi.nlm.nih.gov/pubmed/18312418
Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role.
Yamauchi K, Wada K, Tanji K, Tanaka M, Kamitani T.
Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
PMID: 18312418 [PubMed - indexed for MEDLINE]

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/16887163
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
Javanbakht H, An P, Gold B, Petersen DC, O'Huigin C, Nelson GW, O'Brien SJ, Kirk GD, Detels R, Buchbinder S, Donfield S, Shulenin S, Song B, Perron MJ, Stremlau M, Sodroski J, Dean M, Winkler C.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 16887163 [PubMed - indexed for MEDLINE]

Лозанна, Швейцария

http://www.ncbi.nlm.nih.gov/pubmed/18166079
Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV, Reynard S, Serhan F, Turelli P, Trono D.
Global Health Institute, School of Life Sciences, Frontiers in Genetics National Center for Competence in Research, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
PMID: 18166079 [PubMed - indexed for MEDLINE]   PMCID: PMC2156100

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/17543365
Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
Li X, Song B, Xiang SH, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 17543365 [PubMed - indexed for MEDLINE]   PMCID: PMC2040257

Чикаго, США

http://www.ncbi.nlm.nih.gov/pubmed/17392513
TRIM5 alpha cytoplasmic bodies are highly dynamic structures.
Campbell EM, Dodding MP, Yap MW, Wu X, Gallois-Montbrun S, Malim MH, Stoye JP, Hope TJ.
Department of Cell and Molecular Biology, Northwestern University, Chicago, IL 60611-3008, USA.
PMID: 17392513 [PubMed - indexed for MEDLINE]   PMCID: PMC1877106

Рочестер, США

http://www.ncbi.nlm.nih.gov/pubmed/17609277
Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.
Sakuma R, Mael AA, Ikeda Y.
Molecular Medicine Program, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
PMID: 17609277 [PubMed - indexed for MEDLINE]   PMCID: PMC2045407

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/17156811
Unique features of TRIM5alpha among closely related human TRIM family members.
Li X, Gold B, O'hUigin C, Diaz-Griffero F, Song B, Si Z, Li Y, Yuan W, Stremlau M, Mische C, Javanbakht H, Scally M, Winkler C, Dean M, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 17156811 [PubMed - indexed for MEDLINE]
                                                                 

Бостон, США
http://www.ncbi.nlm.nih.gov/pubmed/17135314
The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ, Stremlau M, Lee M, Javanbakht H, Song B, Sodroski J.
Dana-Farber Cancer Institute, 44 Binney Street, JFB 824, Boston, MA 02115, USA.
PMID: 17135314 [PubMed - indexed for MEDLINE]   PMCID: PMC1865943

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/16472833
Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5.
Diaz-Griffero F, Li X, Javanbakht H, Song B, Welikala S, Stremlau M, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 16472833 [PubMed - indexed for MEDLINE]

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/16643975
Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.
Stremlau M, Song B, Javanbakht H, Perron M, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 16643975 [PubMed - indexed for MEDLINE]

Лондон, Великобритания

http://www.ncbi.nlm.nih.gov/pubmed/16912305
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
Ohkura S, Yap MW, Sheldon T, Stoye JP.
Division of Virology, National Institute for Medical Research, Medical Research Council, London, UK.
PMID: 16912305 [PubMed - indexed for MEDLINE]   PMCID: PMC1563890

Сиэтл, США

http://www.ncbi.nlm.nih.gov/pubmed/17588933
Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein.
Kaiser SM, Malik HS, Emerman M.
Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA.
PMID: 17588933 [PubMed - indexed for MEDLINE]

Осака, Япония

http://www.ncbi.nlm.nih.gov/pubmed/17406861
Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro.
Nakayama EE, Carpentier W, Costagliola D, Shioda T, Iwamoto A, Debre P, Yoshimura K, Autran B, Matsushita S, Theodorou I.
Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita-shi, Osaka, Japan.
PMID: 17406861 [PubMed - indexed for MEDLINE]
                                                                 

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/15280539
TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 15280539 [PubMed - indexed for MEDLINE]   PMCID: PMC511059
                                                                 

Бостон, США
 
http://www.ncbi.nlm.nih.gov/pubmed/15709033
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M, Perron M, Welikala S, Sodroski J.
Dana-Farber Cancer Institute, 44 Binney St., JFB 824, Boston, MA 02115, USA.
PMID: 15709033 [PubMed - indexed for MEDLINE]   PMCID: PMC548447

Яннан, Китай

http://www.ncbi.nlm.nih.gov/pubmed/16226405
Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection.
Liu HL, Wang YQ, Liao CH, Kuang YQ, Zheng YT, Su B.
Kunming Primate Research Center, Chinese Academy of Sciences, Kunming, Yunnan, China.

Вашингтон, США

http://www.ncbi.nlm.nih.gov/pubmed/16401428
High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans.
Sawyer SL, Wu LI, Akey JM, Emerman M, Malik HS.
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
PMID: 16401428 [PubMed - indexed for MEDLINE]
                             

Лондон, Великобритания

http://www.ncbi.nlm.nih.gov/pubmed/15649369
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
Yap MW, Nisole S, Stoye JP.
Division of Virology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
PMID: 15649369 [PubMed - indexed for MEDLINE]

Сиэтл, США

http://www.ncbi.nlm.nih.gov/pubmed/16474153
Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC, Livingston-Rosanoff D, Li SS, Vu Q, Bui J, Geraghty DE, Zhao LP, McElrath MJ.
Medical Scientist Training Program, Molecular and Cellular Biology Program, University of Washington, Seattle, 98109, USA.
PMID: 16474153 [PubMed - indexed for MEDLINE]   PMCID: PMC1395369

Бечезда, США

http://www.ncbi.nlm.nih.gov/pubmed/12878161
BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta.
Xu L, Yang L, Moitra PK, Hashimoto K, Rallabhandi P, Kaul S, Meroni G, Jensen JP, Weissman AM, D'Arpa P.
Department of Biochemistry and Molecular Biology, F. Edward Hèbert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA.
PMID: 12878161 [PubMed - indexed for MEDLINE]

Нэшвил, США

http://www.ncbi.nlm.nih.gov/pubmed/16624363
Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid.
Shi J, Aiken C.
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, A-5301 Medical Center North, Nashville, TN 37232-2363, USA.
PMID: 16624363 [PubMed - indexed for MEDLINE]

Нью-Йорк, США

http://www.ncbi.nlm.nih.gov/pubmed/15919943
Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Berthoux L, Sebastian S, Sayah DM, Luban J.
Department of Microbiology, Columbia University College of Physicians and Surgeons, 701 West 168th St., New York, NY 10032, USA.
PMID: 15919943 [PubMed - indexed for MEDLINE]   PMCID: PMC1143641

Массачусетс, США

http://www.ncbi.nlm.nih.gov/pubmed/14985764
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
PMID: 14985764 [PubMed - indexed for MEDLINE]

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/15767395
Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
Song B, Javanbakht H, Perron M, Park DH, Stremlau M, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA, USA.
PMID: 15767395 [PubMed - indexed for MEDLINE]   PMCID: PMC1061569

Бостон, США

http://www.ncbi.nlm.nih.gov/pubmed/16887163
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
Javanbakht H, An P, Gold B, Petersen DC, O'Huigin C, Nelson GW, O'Brien SJ, Kirk GD, Detels R, Buchbinder S, Donfield S, Shulenin S, Song B, Perron MJ, Stremlau M, Sodroski J, Dean M, Winkler C.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
PMID: 16887163 [PubMed - indexed for MEDLINE]

Чикаго, США

http://www.ncbi.nlm.nih.gov/pubmed/16973579
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
Anderson JL, Campbell EM, Wu X, Vandegraaff N, Engelman A, Hope TJ.
Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Ward 8-140, 303 East Chicago Avenue, Chicago, IL 60611, USA.
PMID: 16973579 [PubMed - indexed for MEDLINE]   PMCID: PMC1617233

Ла Джола, США

http://www.ncbi.nlm.nih.gov/pubmed/17028189
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entry.
Chatterji U, Bobardt MD, Gaskill P, Sheeter D, Fox H, Gallay PA.
Departments of Immunology, Molecular and Integrative Neurosciences, and Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
PMID: 17028189 [PubMed - indexed for MEDLINE]

Лондон, Великобритания

http://www.ncbi.nlm.nih.gov/pubmed/15249690
Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW, Nisole S, Lynch C, Stoye JP.
Division of Virology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
PMID: 15249690 [PubMed - indexed for MEDLINE]   PMCID: PMC490012

Лондон, Великобритания

http://www.ncbi.nlm.nih.gov/pubmed/15249687
The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
Keckesova Z, Ylinen LM, Towers GJ.
Wohl Virion Center, Division of Infection and Immunity, University College London, London W1T 4JF, United Kingdom.
PMID: 15249687 [PubMed - indexed for MEDLINE]   PMCID: PMC490011

Нью-Йорк, США

http://www.ncbi.nlm.nih.gov/pubmed/15249685
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD.
Aaron Diamond AIDS Research Center, New York, NY 10016, USA.
PMID: 15249685 [PubMed - indexed for MEDLINE]   PMCID: PMC490010

Саитама, Япония

http://www.ncbi.nlm.nih.gov/pubmed/16289103
A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons.
Asaoka K, Ikeda K, Hishinuma T, Horie-Inoue K, Takeda S, Inoue S.
Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical School, Saitama, Japan.
PMID: 16289103 [PubMed - indexed for MEDLINE]

Нью-Йорк, США

http://www.ncbi.nlm.nih.gov/pubmed/16501094
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Sokolskaja E, Berthoux L, Luban J.
Department of Microbiology, Columbia University, 701 West 168th Street, New York, New York 10032, USA.
PMID: 16501094 [PubMed - indexed for MEDLINE]   PMCID: PMC1395419

Бостон- Массачусетс, США

http://www.ncbi.nlm.nih.gov/pubmed/14985764
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J.
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
PMID: 14985764 [PubMed - indexed for MEDLINE]

Другие статьи на эту тему: http://www.ncbi.nlm.nih.gov/sites/entrez?db=pmc&cmd=search&term=TRIM5alpha%20HIV-1